Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
NRG Oncology
Sir Mortimer B. Davis - Jewish General Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
University of Michigan Rogel Cancer Center